177 related articles for article (PubMed ID: 24884596)
1. Women's expectations and experiences of hormone treatment for sexual dysfunction.
Fooladi E; Bell RJ; Whittaker AM; Davis SR
Climacteric; 2014 Dec; 17(6):674-81. PubMed ID: 24884596
[TBL] [Abstract][Full Text] [Related]
2. Re: Women's expectations and experiences of hormone treatment for sexual dysfunction.
Seftel AD
J Urol; 2015 Jan; 193(1):250. PubMed ID: 25523687
[No Abstract] [Full Text] [Related]
3. The relationship between same-sex sexual experience, sexual distress, and female sexual dysfunction.
Burri A; Rahman Q; Santtila P; Jern P; Spector T; Sandnabba K
J Sex Med; 2012 Jan; 9(1):198-206. PubMed ID: 22082180
[TBL] [Abstract][Full Text] [Related]
4. How Do Psychological Risk Factors Predict Sexual Outcomes? A Comparison of Four Models of Young Women's Sexual Outcomes.
Tutino JS; Ouimet AJ; Shaughnessy K
J Sex Med; 2017 Oct; 14(10):1232-1240. PubMed ID: 28830740
[TBL] [Abstract][Full Text] [Related]
5. Sexual dysfunction among reproductive-aged Chinese married women in Hong Kong: prevalence, risk factors, and associated consequences.
Zhang H; Fan S; Yip PS
J Sex Med; 2015 Mar; 12(3):738-45. PubMed ID: 25470214
[TBL] [Abstract][Full Text] [Related]
6. Treating women's sexual difficulties: the body work of sexual therapy.
Cacchioni T; Wolkowitz C
Sociol Health Illn; 2011 Feb; 33(2):266-79. PubMed ID: 21241336
[TBL] [Abstract][Full Text] [Related]
7. "If sex hurts, am I still a woman?" the subjective experience of vulvodynia in hetero-sexual women.
Ayling K; Ussher JM
Arch Sex Behav; 2008 Apr; 37(2):294-304. PubMed ID: 17876696
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic options for postmenopausal female sexual dysfunction.
Al-Azzawi F; Bitzer J; Brandenburg U; Castelo-Branco C; Graziottin A; Kenemans P; Lachowsky M; Mimoun S; Nappi RE; Palacios S; Schwenkhagen A; Studd J; Wylie K; Zahradnik HP
Climacteric; 2010 Apr; 13(2):103-20. PubMed ID: 19958161
[TBL] [Abstract][Full Text] [Related]
9. Placebo response in the treatment of women's sexual dysfunctions: a review and commentary.
Bradford A; Meston CM
J Sex Marital Ther; 2009; 35(3):164-81. PubMed ID: 19360517
[TBL] [Abstract][Full Text] [Related]
10. A qualitative study of heterosexual women's attempts to renegotiate sexual relationships in the context of severe sexual problems.
Hinchliff S; Gott M; Wylie K
Arch Sex Behav; 2012 Oct; 41(5):1253-61. PubMed ID: 22318469
[TBL] [Abstract][Full Text] [Related]
11. Presence of a sexual problem may not affect women's satisfaction from their sexual function.
Ferenidou F; Kapoteli V; Moisidis K; Koutsogiannis I; Giakoumelos A; Hatzichristou D
J Sex Med; 2008 Mar; 5(3):631-9. PubMed ID: 17971103
[TBL] [Abstract][Full Text] [Related]
12. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
Gregersen N; Jensen PT; Giraldi AE
Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
[TBL] [Abstract][Full Text] [Related]
13. Perceptions of female sexual health and sexual dysfunction in a cohort of urban professional women in Abuja, Nigeria.
Aisuodionoe-Shadrach OI
Niger J Clin Pract; 2012; 15(1):80-3. PubMed ID: 22437096
[TBL] [Abstract][Full Text] [Related]
14. Attributions about pain as predictors of psychological symptomatology, sexual function, and dyadic adjustment in women with vestibulodynia.
Jodoin M; Bergeron S; Khalifé S; Dupuis MJ; Desrochers G; Leclerc B
Arch Sex Behav; 2011 Feb; 40(1):87-97. PubMed ID: 20652736
[TBL] [Abstract][Full Text] [Related]
15. Drugs in early clinical development for the treatment of female sexual dysfunction.
Belkin ZR; Krapf JM; Goldstein AT
Expert Opin Investig Drugs; 2015 Feb; 24(2):159-67. PubMed ID: 25376023
[TBL] [Abstract][Full Text] [Related]
16. A phase 2a multicenter, double-blind, placebo-controlled, crossover trial to investigate the efficacy, safety, and toleration of CP-866,087 (a high-affinity mu-opioid receptor antagonist) in premenopausal women diagnosed with female sexual arousal disorder (FSAD).
Orri M; Abraham L; Giraldi A
J Sex Med; 2013 Oct; 10(10):2484-96. PubMed ID: 23347610
[TBL] [Abstract][Full Text] [Related]
17. Female sexual satisfaction and pharmaceutical intervention: a critical review of the drug intervention studies in female sexual dysfunction.
Nijland E; Davis S; Laan E; Schultz WW
J Sex Med; 2006 Sep; 3(5):763-777. PubMed ID: 16942521
[TBL] [Abstract][Full Text] [Related]
18. Low relationship satisfaction and high partner involvement predict sexual problems of women with fibromyalgia.
Kool MB; Woertman L; Prins MA; Van Middendorp H; Geenen R
J Sex Marital Ther; 2006; 32(5):409-23. PubMed ID: 16959664
[TBL] [Abstract][Full Text] [Related]
19. Help-seeking behaviors for female sexual dysfunction: a cross sectional study from Iran.
Vahdaninia M; Montazeri A; Goshtasebi A
BMC Womens Health; 2009 Feb; 9():3. PubMed ID: 19250522
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics and sexuality: a vision.
Nappi RE; Domoney C
Climacteric; 2013 Aug; 16 Suppl 1():25-30. PubMed ID: 23848488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
